Showing 1-20 of 372 for: Cochrane Systematic Reviews > Oncology 
- 5-alpha-reductase inhibitors for prostate cancer prevention
Cochrane Systematic Reviews, 17-Jan-2012
Five-alpha-reductase inhibitors (5ARI) are frequently used to treat bothersome lower urinary tract symptoms associated with benign prostatic hyperplasia and male androgenic alopecia. They have potential as chemopreventive agents.
- Abdominal drainage versus no drainage post‐gastrectomy for gastric cancer
Cochrane Systematic Reviews, 11-May-2015
Gastrectomy remains the primary therapeutic method for resectable gastric cancer. Thought of as an important measure to reduce post-operative complications and mortality, abdominal drainage has been used widely after gastrectomy for gastric cancer in prev
- Acupuncture for cancer pain in adults
Cochrane Systematic Reviews, 15-Oct-2015
Forty per cent of individuals with early or intermediate stage cancer and 90% with advanced cancer have moderate to severe pain and up to 70% of patients with cancer pain do not receive adequate pain relief. It has been claimed that acupuncture has a role
- Addition of drug/s to a chemotherapy regimen for metastatic breast cancer
Cochrane Systematic Reviews, 10-Nov-2010
The addition of a chemotherapy drug or drugs to an established regimen is one method used to increase the dose and intensity of treatment for metastatic breast cancer.
- Adjuvant chemotherapy for endometrial cancer after hysterectomy
Cochrane Systematic Reviews, 5-Oct-2011
Endometrial adenocarcinoma (womb cancer) is a malignant growth of the lining (endometrium) of the womb (uterus). It is distinct from sarcomas (tumours of the uterine muscle). Survival depends the risk of microscopic metastases after surgery. Adjuvant (pos
- Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
Cochrane Systematic Reviews, 19-Apr-2006
Controversy exists as to whether adjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite a number of randomised controlled trials.
- Adjuvant chemotherapy for small intestine adenocarcinoma
Cochrane Systematic Reviews, 18-Jul-2007
Although the small intestine represents 75% of the length and over 90% of the mucosal surface of the alimentary tract, it is the site of only about 2% of malignant gastrointestinal tumours. Adenocarcinoma is the most common histological subtype, accountin
- Adjuvant platinum‐based chemotherapy for early stage cervical cancer
Cochrane Systematic Reviews, 22-Nov-2016
This is the second updated version of the original Cochrane review published in the Cochrane Library 2009, Issue 3.?Most women with early cervical cancer (stages I to IIA) are cured with surgery or radiotherapy, or both. We performed this review originall
- Adjuvant progestagens for endometrial cancer
Cochrane Systematic Reviews, 11-Feb-2015
Endometrial cancer is the most common genital tract carcinoma among women in developed countries, with most women presenting with stage 1 disease. Adjuvant progestagen therapy has been advocated following primary surgery to reduce the risk of recurrence o
- Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma
Cochrane Systematic Reviews, 28-Feb-2013
Uterine carcinosarcomas are uncommon with about 35% not confined to the uterus at diagnosis. The survival of women with advanced uterine carcinosarcoma is poor with a pattern of failure indicating greater likelihood of upper abdominal and distant metastat
- Adjuvant radiotherapy following radical prostatectomy for prostate cancer
Cochrane Systematic Reviews, 13-Oct-2011
Men who have a radical prostatectomy (RP) for prostate cancer that does not involve lymph nodes, but extends beyond the prostate capsule into the seminal vesicles or to surgical margins, are at increased risk of relapse. In men with these high risk factor
- Adjuvant radiotherapy for stage I endometrial cancer
Cochrane Systematic Reviews, 18-Apr-2012
This is an updated version of the original Cochrane review published in Issue 2, 2007. The role of radiotherapy (both pelvic external beam radiotherapy (EBRT) and vaginal intracavity brachytherapy (VBT)) in stage I endometrial cancer following hysterectom
- Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas
Cochrane Systematic Reviews, 15-May-2014
Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. The benefit of adjuvant chemotherapy and radiotherapy (RT), given as single modalities or sequentially, is still unc
- Alemtuzumab for patients with chronic lymphocytic leukaemia
Cochrane Systematic Reviews, 15-Feb-2012
Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in Western countries. Standard treatment includes mono- or poly-chemotherapies. Nowadays, monoclonal antibodies are added, especially alemtu
- Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission
Cochrane Systematic Reviews, 9-Aug-2011
Consolidation chemotherapy, autologous hematopoietic cell transplantation (HCT) and allogeneic HCT represent potential treatment alternatives for post-remission therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty regardin
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
Cochrane Systematic Reviews, 29-Aug-2013
Primary cutaneous T-cell lymphomas (CTCL) belong to the group of non-Hodgkin lymphomas and usually run an indolent course. However, some patients progress to advanced tumour or leukaemic stages. To date, there is no cure for those cases. In the last few y
- Alpha‐foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B
Cochrane Systematic Reviews, 12-Sep-2012
Chronic hepatitis B virus infection is a risk factor for development of hepatocellular carcinoma. Alpha-foetoprotein and liver ultrasonography are used to screen patients with chronic hepatitis B for hepatocellular carcinoma. It is uncertain whether scree
- Amifostine for salivary glands in high‐dose radioactive iodine treated differentiated thyroid cancer
Cochrane Systematic Reviews, 6-Oct-2009
Radioactive iodine treatment for differentiated thyroid cancer possibly results in xerostomia. Amifostine has been used to prevent the effects of irradiation to salivary glands. To date, the effects of amifostine on salivary glands in radioactive iodine t
- Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia
Cochrane Systematic Reviews, 4-Sep-2014
Patients with cancer who are treated with chemotherapy or receive a bone marrow transplant have an increased risk of acquiring fungal infections. Such infections can be life-threatening. Antifungal drugs are therefore often given prophylactically to such
- Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
Cochrane Systematic Reviews, 4-Sep-2014
Systemic fungal infection is considered to be an important cause of morbidity and mortality in cancer patients, particularly those with neutropenia. Antifungal drugs are often given prophylactically, or empirically to patients with persistent fever.
